Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 814 results for "zydus cadila"

Cadila Healthcare jumps 2% on acquiring Zydus BSV
India Infoline

Cadila Healthcare in the pink of health

after the company said it has purchased 50% shares of Zydus BSV Pharma from Bharat Serums and Vaccines and now Zydus BSV has become 100% subsidiary of Cadila Healthcare. The announcement was made after market hours yesterday, 26 March 2015. Meanwhile, the S ... Business Standard, 1 hour ago
Cadila Healthcare jumps 2% on acquiring Zydus BSV India Infoline, 2 hours ago

9 images for zydus cadila

Money Control, 1 week ago, 1 week ago
Odisha Samaya, 1 week ago
Money Control, 2 hours ago
India Infoline, 2 hours ago
India Infoline, 1 week ago
Business Standard, 1 month ago
Business Standard India, 1 month ago
Mumbai Mirror, 2 months ago
Odisha Samaya

Cadila Healthcare launches Hepatitis C drug SoviHep

New Delhi: Cadila Healthcare or Zydus Cadila has announced to launch an oral therapy SoviHep for the treatment of Hepatitis C. It is the Ahmedabad-based pharma major Cadila Healthcare has launched Hepatitis C drug and would be marketed by the ...
 Odisha Samaya1 week ago Cadila spurts 4% at opening bell  India Infoline1 week ago Zydus launches SoviHep - the breakthrough therapy for Hepatitis C  Moneycontrol.com1 week ago Cadila Healthcare spurts on launching SoviHep  Capital Market1 week ago
Money Control

Zydus Cadila Launches Generic Version of Gilead Sciences’ Hepatitis C drug in India

Pharmaceutical companies across the globe have been spending lot of money in research to find out effective treatments for Hepatitis C. In India, more than 10 million people suffer from Hepatitis C, which was earlier considered to be an incurable problem.
 TopNews1 week ago Zydus Cadila, Gilead Sciences ink non-exclusive licensing pact  Indian-Commodity1 week ago Zydus Cadila launches Gilead's Hepatitis C drug in India  Hindu Business Line1 week ago Gilead Sciences, Inc. Under Severe Criticism For HCV Drug Restrictions  Mr Top Step1 week ago

Buy Cadila Healthcare; target Rs 1727: Firstcall Research

Firstcall Research's report on Cadila Healthcare For the 3rd quarter ended Dec 31st, 2014, Zydus Cadila reported Net sales of Rs 21894.60 mn, up by 16.98% from Rs. 18716.90 mn in the corresponding quarter of the previous year on a consolidated ...
 Moneycontrol.com1 month ago Zydus Cadila Q3 profit up 52%  Hindu Business Line1 month ago Zydus Cadila Q3 net jumps 52%  Hindu Business Line1 month ago Zydus Cadila Net Profit up by 52% in Q3  FiercePharma1 month ago
Business Standard India

Zydus completes Phase I studies on molecule for treating anemia

City-based pharmaceutical major, Zydus Cadila announced completion of the single ascending dose (SAD) study of ZYAN1 molecule as part of phase-1 study ongoing in Australia. The molecule, ZYAN1 is an orally bioavailable hypoxia-inducible ...
 Hindu Business Line1 month ago Zydus completes single rising dose Phase I studies for its oral HIF inhibitor, ZYAN1  Money Control1 month ago Zydus completes single ascending dose Phase I trial of anaemia drug ZYAN1  Pharmaceutical Business Review1 month ago Zydus completes Phase I trials of anaemia drug  Business Standard India1 month ago
Pharma Letter

Zydus Cadila to make presentation on Saroglitazar at Keystone Symposia

AHMEDABAD: Zydus Cadila group will be making an oral presentation on Saroglitazar, a novel compound under development for treatment in Non-alcoholic Steatohepatitis (NASH), at the Keystone Symposium on Liver Metabolism and Non-alcoholic Fatty Liver ...
 Times of India1 month ago Cadila Healthcare intimates presentation of Saroglitazar for treatment of NASH  Business Standard India1 month ago Indian company Zydus to present data on Lipaglyn in steatohepatitis  Pharma Letter1 month ago Zydus to present data from Saroglitazar to treat NASH at Keystone Symposium  PharmaBiz1 month ago

Zydus Wellness launches herbal variant of Sugar Free

Related to : Zydus Wellness Ltd,Cadila Healthcare Ltd Zydus Wellness Ltd BSE 11 Feb 15 | 12:00 AM 818.10 -20.25 (-2.42%) NSE 11 Feb 15 | 12:00 AM 820.95 -20.3 (-2.41%) Zydus Wellness, the consumer products arm of Ahmedabad-based ...
 Smart Investor1 month ago Zydus Wellness plans new launches under Everyuth  Agencyfaqs!1 month ago


The US Food and Drug Administration (USFDA) has notified that Zydus Pharmaceuticals USA , the US subsidiary of Cadila Healthcare , has voluntarily recalled 19,536 bottles of benzonatate capsules. The drug indicated for the treatment ...
 4 Traders2 months ago Cadila recalls 19,536 bottles of cough treatment drug in US  Business Standard India2 months ago Cadila recalls cough treatment drug in U.S.  The Hindu2 months ago Cadila Healthcare recalls cough treatment drug in US  Indian-Commodity2 months ago

Zydus Cadila ups vaccines game with programs for Ebola, Congo fever

Ebolavirus under an electron microscope--Courtesy of CDC The latest drugmaker diving into the Ebola vaccine race? India's Zydus Cadila. The pharma is developing jabs for the deadly virus and tick-borne viral Crimean-Congo hemorrhagic fever, The ...
 FierceVaccines2 months ago Zydus Cadila developing Ebola, Congo fever vaccines  Times of India2 months ago
Manufacturing Chemist

Rapid, reliable filling of liquid injectables

Abstract Zydus Cadila recently expanded its sterile injectables filling operations. Nicola Magriotis, Romaco, explains why its Macofar VF 18 aseptic vial filler was ideal for
 Manufacturing Chemist1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus cadila
Get updated on latest news & your favorite topics right in your inbox!
More     Less